| Company Name: | UnitedHealth Group Inc | | Ticker Symbol: | UNH | | CIK Number: | 0000731766 | | WWW Address: | http://www.unitedhealthgroup.com |
| CEO: | David S. Wichmann | | No. of Employees: | 230,000 |
| Common Issue Type: | CS | | Business Description: | UnitedHealth Group, Inc. designs products, provides services and applies technologies that improve access to health and well-being services, simplify the health care experience and make health care more affordable.
|
| | | Industry Information: | HEALTH SERVICES - Health Care Plans [more like this] |
| | Price | Day Change | Bid | Ask | Open | High | Low | Volume | | 261.46 |  0.0 | - | - | | 256.92 | 242.22 | - |
| Market Cap (mil) | Shares Outstanding (mil) | Beta | EPS | DPS | P/E | Yield | 52-Wks-Range |
| 251,533.5 | 962.0 | 0.00 | 10.95 | 3.60 | 22.4 | 1.4 | 287.94 - 208.48 |
| | KEY FIGURES (Latest Twelve Months - LTM) | | Yesterday's Close | 256.84 | $ | | PE Ratio - LTM | 22.4 | |
| Market Capitalisation | 251,533.5 | mil |
| Latest Shares Outstanding | 962.0 | mil |
| Earnings pS (EPS) | 10.95 | $ |
| Dividend pS (DPS) | 3.60 | ¢ |
| Dividend Yield | 1.4 | % |
| Dividend Payout Ratio | | % |
| Revenue per Employee | 831,714 | $ |
| Effective Tax Rate | 35.9 | % |
| Float | 954.9 | mil |
| Float as % of Shares Outstanding | 1.0 | % |
| Foreign Sales | - | |
| Domestic Sales | - | |
| Selling, General & Adm/tive (SG&A) as % of Revenue | - | |
| Research & Devlopment (R&D) as % of Revenue | - | |
| Gross Profit Margin | - | |
| EBITDA Margin | 0.0 | % |
| Pre-Tax Profit Margin | 0.0 | % |
| Assets Turnover | 0.0 | % |
| Return on Assets (ROA) | 0.0 | % |
| Return on Equity (ROE) | 0.0 | % |
| Return on Capital Invested (ROCI) | 0.0 | % |
| Current Ratio | - | |
| Leverage Ratio (Assets/Equity) | | |
| Interest Cover | | |
| Total Debt/Equity (Gearing Ratio) | | |
| LT Debt/Total Capital | 0.0 | % |
| Working Capital pS | - | |
| Cash pS | - | |
| Book-Value pS | 51.98 | $ |
| Tangible Book-Value pS | -15.87 | $ |
| Cash Flow pS | 10.90 | $ |
| Free Cash Flow pS | 8.73 | $ |
 |
| KEY FIGURES (LTM): Price info |
| Price/Book Ratio | 4.76 | |
| Price/Tangible Book Ratio | 0.00 | |
| Price/Cash Flow | 22.7 | |
| Price/Free Cash Flow | 28.4 | |
| P/E as % of Industry Group | 58.0 | % |
| P/E as % of Sector Segment | 80.0 | % |
| | | Balance Sheet (at a glance) in Millions |
| | | | | | DIVIDEND INFO | | Type of Payment | Cash Payment |
| Dividend Rate | 3.60 |
| Current Dividend Yield | 1.4 |
| 5-Y Average Dividend Yield | 0.9 |
| Payout Ratio | 0.0 |
| 5-Y Average Payout Ratio | 8.0 |
| |
| |
| |
| |
| |
|  | | Share price performance previous 3 years |
|
 | | | Share price performance intraday |
|
 | | | | | PRICE/VOLUME | High | Low | Close | % Price Chg | % Price Chg vs. Mkt. | Avg. Daily Vol | Total Vol |
| 1 Week | - | - | - | 5.4 | | 3,563,368 | 9,148,145 |
| 4 Weeks | 256.92 | 231.81 | 250.31 | 2.6 | | 3,875,495 | 69,758,926 |
| 13 Weeks | 287.94 | 231.81 | 267.30 | -3.9 | | 3,480,635 | 212,318,736 |
| 26 Weeks | 287.94 | 231.81 | 255.44 | 0.6 | | 2,834,170 | 354,271,342 |
| 52 Weeks | 287.94 | 208.48 | 238.43 | 7.7 | | 2,922,824 | 733,628,916 |
| YTD | 256.92 | 236.13 | - | 5.5 | | 3,563,368 | 35,633,688 |
| Moving Average | 5-Days | 10-Days | 10-Weeks | 30-Weeks | 200-Days | Beta (60-Mnth) | Beta (36-Mnth) |
| 248.13 | 244.38 | 259.95 | 260.22 | 254.18 | 0.00 | 0.00 |
| | | | GROWTH RATES | 5-Year
Growh | R² of 5-Year Growth | 3-Year
Growth |
| Revenue | | 0.0 | |
| Income | | 0.0 | |
| Dividend | | 0.0 | |
| Capital Spending | | NA | |
| R&D | 0.00 | NA | 0.00 |
| Normalized Inc. | 0.00 | NA | 0.00 |
| | | CHANGES | YTD vs.
Last YTD | Curr Qtr vs.
Qtr 1-Yr ago | Annual vs.
Last Annual |
| Revenue % | 11.2 | 11.2 | 8.6 |
| Earnings % | -10.7 | -10.7 | 7.5 |
| EPS % | -11.5 | -11.5 | 11.6 |
| EPS $ | -0.15 | -0.15 | 0.55 |
| | | | SOLVENCY RATIOS | | SHORT-TERM SOLVENCY RATIOS (LIQUIDITY) |
| |
| |
| |
| |
| FINANCIAL STRUCTURE RATIOS |
| Financial Leverage Ratio (Assets/Equity) | 2.91 |
| Debt Ratio | 65.64 |
| Total Debt/Equity (Gearing Ratio) | 0.66 |
| LT Debt/Equity | 0.60 |
| LT Debt/Capital Invested | 37.64 |
| LT Debt/Total Liabilities | 31.59 |
| | | | VALUATION RATIOS | | MULTIPLES |
| PQ Ratio | 0.00 |
| Tobin's Q Ratio | 1.82 |
| Current P/E Ratio - LTM | 22.40 |
| Enterprise Value (EV)/EBITDA | 0.00 |
| Enterprise Value (EV)/Free Cash Flow | 36.98 |
| Dividend Yield | 1.4 |
| Price/Tangible Book Ratio - LTM | 0.00 |
| Price/Book Ratio - LTM | 4.76 |
| Price/Cash Flow Ratio | 22.7 |
| Price/Free Cash Flow Ratio - LTM | 28.4 |
| P/E Ratio (1 month ago) - LTM | 12.2 |
| P/E Ratio (26 weeks ago) - LTM | 10.3 |
| P/E Ratio (52 weeks ago) - LTM | 12.2 |
| 5-Y High P/E Ratio | 22.6 |
| 5-Y Low P/E Ratio | 5.5 |
| 5-Y Average P/E Ratio | 10.1 |
| Current P/E Ratio as % of 5-Y Average P/E | 38 |
| P/E as % of Industry Group | 58.0 |
| P/E as % of Sector Segment | 80.0 |
| Current 12 Month Normalized P/E Ratio - LTM | 12.5 |
| PER SHARE FIGURES |
| Tangible Book Value pS - LTM | -15.87 |
| Book Value pS - LTM | 51.98 |
| Capital Invested pS | 79.63 |
| Cash Flow pS - LTM | 10.90 |
| Free Cash Flow pS - LTM | 8.73 |
| Earnings pS (EPS) | 10.95 |
| | | | OPERATING RATIOS | | PROFITABILITY |
| Return on Equity (ROE) | 22.10 |
| Return on Equity (ROE) - 5YEAR AVRG. | |
| Return on Capital Invested (ROCI) | 13.29 |
| Return on Capital Invested (ROCI) - 5YEAR AVRG. | |
| Return on Assets (ROA) | 7.59 |
| Return on Assets (ROA) - 5YEAR AVRG. | |
| EBIT Margin - LTM | 0.0 |
| EBITDA Margin - LTM | 0.0 |
| |
| |
| |
| |
| |
| |
| EFFICIENCY RATIOS |
| Revenue per Employee - LTM | 854,707 |
| Net Income per Employee - LTM | 40,436 |
| Assets/Revenue - LTM | 18.52 |
| |
|
|  
| | |  |  | | |
